Characterization of GABAergic Marker Expression in the Chronic Unpredictable Stress Model of Depression
Open accessThe DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Abstract
Background: Evidence continues to build suggesting that the GABAergic neurotransmitter system is altered in brains of patients with major depressive disorder. However, there is little information available related to the extent of these changes or the potential mechanisms associated with these alterations. As stress is a well-established precipitant to depressive episodes, we sought to explore the impact of chronic stress on GABAergic interneurons. Methods: Using western blot analyses and quantitative real-time polymerase chain reaction, we assessed the effects of five-weeks of chronic unpredictable stress exposure on the expression of GABA-synthesizing enzymes (GAD 65 and GAD 67), calcium-binding proteins (calbindin, parvalbumin, and calretinin), and neuropeptides co-expressed in GABAergic neurons (somatostatin, neuropeptide Y, vasoactive intestinal peptide, and cholecystokinin) in the prefrontal cortex and hippocampus of rats. We also investigated the effects of corticosterone and dexamethasone exposure on these markers in vitro in primary cortical and hippocampal cultures. Results: We found that chronic unpredictable stress induced significant reductions of GAD 67 protein levels in both the prefrontal cortex and hippocampus of chronic unpredictable stress-exposed rats but did not detect changes in GAD 65 protein expression. Similar protein expression changes were found in vitro in cortical neurons. In addition, our results provide clear evidence of reduced markers of interneuron population(s), namely somatostatin and neuropeptide Y, in the prefrontal cortex, suggesting these cell types may be selectively vulnerable to chronic stress. Conclusion: Together, this work highlights that chronic stress induces regional and cell type-selective effects on GABAergic interneurons in rats. These findings provide additional supporting evidence that stress-induced GABA neuron dysfunction and cell vulnerability play critical roles in the pathophysiology of stress-related illnesses, including major depressive disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Decreases in SST expression are detected in the dorsolateral prefrontal cortex and subgenual anterior cingulate cortex of depressed patients as well as the prefrontal cortex of mice exposed to chronic unpredictable stress, while changes in PV are less consistent [134-136].”
From An emerging circuit pharmacology of GABAA receptors (2018) · cites this paper as [136]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Decreases in SST expression are detected in the dorsolateral prefrontal cortex and subgenual anterior cingulate cortex of depressed patients as well as the prefrontal cortex of mice exposed to chronic unpredictable stress, while changes in PV are less consistent [134-136].”
From An emerging circuit pharmacology of GABAA receptors (2018) · cites this paper as [136]
In the citing paper
“Somatostatin-and parvalbumin-expressing GABAergic interneurons are particularly affected in chronically stressed rats [209].”
From Plasticity of synapses and reward circuit function in the genesis and treatment of depression (2023) · cites this paper as [209]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391 · cited 1×
“It is estimated that 17% of the population is affected by MDD, yet only approximately one third of patients achieve remission after treatment with current first-line therapeutic agents.(1,2) Attempts to develop novel, improved antidepressant therapies have been hindered by a limited understanding of the precise neurob…”
BackgroundTrivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879 · cited 1×
“It is estimated that 17% of the population is affected by MDD, yet only approximately one third of patients achieve remission after treatment with current first-line therapeutic agents.(1,2) Attempts to develop novel, improved antidepressant therapies have been hindered by a limited understanding of the precise neurob…”
BackgroundTHE EFFECTS OF STRESSFUL LIFE EVENTS ON DEPRESSION
Kessler, R. C. (1997) · Annual Review of Psychology · doi:10.1146/annurev.psych.48.1.191 · Cited by 2,111 · cited 1×
“Stress exposure is a major risk factor for the onset of depression.(25,26) Previous studies have employed stress paradigms to probe pathological changes relevant to MDD within the GABAergic system in the rodent brain.”
BackgroundGABAergic Interneurons in the Neocortex: From Cellular Properties to Circuits
Tremblay, R., Lee, S., & Rudy, B. (2016) · Neuron · doi:10.1016/j.neuron.2016.06.033 · Cited by 2,033 · cited 1×
“It is now recognized that GABAergic interneurons are highly heterogeneous in terms of multiple morphological, electrophysiological, and molecular properties.(15) Co-expression of neurochemical markers, notably the calcium-binding protein parvalbumin (PV), the neuropeptide somatostatin (SST), and vasoactive intestinal…”
BackgroundNeurocircuitry of Mood Disorders
Price, J. L., & Drevets, W. C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.104 · Cited by 1,606
Three groups of interneurons account for nearly 100% of neocortical GABAergic neurons
Rudy, B., Fishell, G., Lee, S., & Hjerling‐Leffler, J. (2011) · Developmental Neurobiology · doi:10.1002/dneu.20853 · Cited by 1,420 · cited 1×
“Co-expression of neurochemical markers, notably the calcium-binding protein parvalbumin (PV), the neuropeptide somatostatin (SST), and vasoactive intestinal peptide (VIP)/ionotropic serotonin receptor 3a, can be used to discriminate between three non-overlapping GABA interneuron populations.(16) Dissecting the role of…”
BackgroundInterneuron dysfunction in psychiatric disorders
Marín, O. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3155 · Cited by 1,190
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment
Pariante, C. M., & Miller, A. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01088-x · Cited by 1,147
Li, N., Liu, R.-J., Dwyer, J. M., Banasr, M., Lee, B., Son, H., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.015 · Cited by 1,082 · cited 1×
“On day 10, cells were exposed to various doses of CORT, DEX (Sigma, MO), or dimethylsulfoxide (DMSO) (vehicle) for 72 h.(43) The doses of CORT (100 nM, 1 mM, 10 mM) and DEX (100 nM and 200 nM) used in this study were shown to induce oxidative stress at this time point.”
MethodSelf-citationThe GABAergic deficit hypothesis of major depressive disorder
Luscher, B., Shen, Q., & Sahir, N. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.120 · Cited by 934 · cited 5×
“Mitochondria oxidative stress and endoplasmic reticulum-related stress have recently been implicated in the pathophysiology of MDD61–64 and recapitulated in rodent models as biomarkers of chronic stress-related damage.65,66 Disruption of the function of these organelles is linked to altered energy balance and protein…”
BackgroundInfluential
Research works printed but not linked: 3
- Kasa K, 1982, Biol Psychiatry, 17, 877
- Shalaby A, 2009, Int J Physiol Pathophysiol Pharmacol, 1, 154
- Fee C, Biol Psychiatry
Cited by
Duman, R. S., Sanacora, G., & Krystal, J. H. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.013 · Cited by 1,026
“Another recent study finds that 5 weeks of CUS decreases protein levels of GAD67, as well as SST and NPY, with a trend for PV in the PFC and/or hippocampus (Banasr et al., 2017); levels of SST and NPY mRNA in the PFC were also decreased.”
BackgroundSelf-citationCortical GABAergic Dysfunction in Stress and Depression: New Insights for Therapeutic Interventions
Fogaça, M. V., & Duman, R. S. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00087 · Cited by 396
“Reduced SST gene expression, mRNA, or protein levels were found in the CSF, SgACC, dlPFC, and amygdala of MDD subjects, and in the medial PFC (mPFC) and hippocampus of animals exposed to CUS (Rubinow et al., 1985; Rajkowska et al., 2007; Sibille et al., 2011; Tripp et al., 2011; Guilloux et al., 2012; Banasr et al., 2…”
BackgroundResultInfluentialSelf-citationSpruit, A., Goos, L., Weenink, N., Rodenburg, R., Niemeyer, H., Stams, G. J., & Colonnesi, C. (2020) · Clinical Child and Family Psychology Review · doi:10.1007/s10567-019-00299-9 · Cited by 280
An emerging circuit pharmacology of GABAA receptors
Engin, E., Benham, R. S., & Rudolph, U. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.04.003 · Cited by 225
Page, C. E., & Coutellier, L. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.07.024 · Cited by 213
Glutamate and GABA Homeostasis and Neurometabolism in Major Depressive Disorder
Sarawagi, A., Soni, N. D., & Patel, A. B. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.637863 · Cited by 165
“Moreover, multiple studies have reported reduced expression of GAD67 and GABA transporters in the brain of MDD subjects (90, 93, 94).”
BackgroundHippocampus: Molecular, Cellular, and Circuit Features in Anxiety
Shi, H., Wang, S., Wang, X., Zhang, R.-X., & Zhu, L. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01020-1 · Cited by 173
“Contradictory results suggest that no changes in the number or expression of PV occur after chronic unpredictable stress or maternal separation [124, 125], and may be due to different types of stressors or stress times.”
ResultNeurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function
Duman, R. S., Shinohara, R., Fogaça, M. V., & Hare, B. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0400-x · Cited by 154
“We found that a single dose of ketamine caused a rapid reversal of anhedonia resulting from CUS exposure, and also rapidly reversed the synaptic deficits caused by CUS [41].”
BackgroundInfluentialSelf-citationCzéh, B., Vardya, I., Varga, Z., Febbraro, F., Csabai, D., Martis, L.-S., Højgaard, K., Henningsen, K., Bouzinova, E. V., Miseta, A., et al. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00148 · Cited by 128
Fogaça, M. V., Wu, M., Li, C., Li, X.-Y., Picciotto, M. R., & Duman, R. S. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00916-y · Cited by 129
Self-citationMcKlveen, J. M., Moloney, R. D., Scheimann, J. R., Myers, B., & Herman, J. P. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.04.032 · Cited by 119
Lüscher, B., & Möhler, H. (2019) · F1000Research · doi:10.12688/f1000research.18758.1 · Cited by 105
Ghosal, S., Duman, C. H., Liu, R.-J., Wu, M., Terwilliger, R., Girgenti, M. J., Wohleb, E., Fogaca, M. V., Teichman, E. M., Hare, B., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104669 · Cited by 89
Self-citationBittar, T. P., & Labonté, B. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.699592 · Cited by 87
Krystal, J. H., Kaye, A. P., Jefferson, S., Girgenti, M. J., Wilkinson, S. T., Sanacora, G., & Esterlis, I. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2305772120 · Cited by 90
“In stressed animals, SST neurons show reduced expression of molecular markers of functional integrity (101).”
BackgroundSelf-citationDiabesity and mood disorders: Multiple links through the microbiota-gut-brain axis
Farzi, A., Hassan, A. M., Zenz, G., & Holzer, P. D. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.11.003 · Cited by 85
Parvalbumin interneuron alterations in stress-related mood disorders: A systematic review
Perlman, G., Tanti, A., & Mechawar, N. (2021) · Neurobiology of Stress · doi:10.1016/j.ynstr.2021.100380 · Cited by 81
Ortiz, J. B., & Conrad, C. D. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2018.02.005 · Cited by 80
Banasr, M., Sanacora, G., & Esterlis, I. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.04.004 · Cited by 75
Self-citationDepressive patient‐derived GABA interneurons reveal abnormal neural activity associated with HTR2C
Lu, K., Hong, Y., Tao, M., Shen, L., Zheng, Z., Fang, K.-H., Yuan, F., Xu, M., Wang, C., Zhu, D., et al. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202216364 · Cited by 68
“…enzyme 67 (GAD67) protein levels, as well as GABAA/B receptor deficits, are observed in animal models of MDD (Luscher et al , 2011; Banasr et al , 2017; Jacobson et al , 2018; Duman et al , 2019), leading to the hypothesis of disrupted structural and functional integrity of…”
Khan, A. R., Geiger, L., Wiborg, O., & Czéh, B. (2020) · Cells · doi:10.3390/cells9041026 · Cited by 70
“But it is generally accepted that chronic stress directly affects various subtypes of GABAergic interneurons in the medial PFC either by reducing the number of specific GABAergic cell types [23] or by reducing the expression of the GABA producing enzyme GAD67 [69,143].”
BackgroundRasmusson, A. M., & Pineles, S. L. (2018) · Current Psychiatry Reports · doi:10.1007/s11920-018-0908-9 · Cited by 65
Pesarico, A. P., Bueno-Fernandez, C., Guirado, R., Gómez-Climent, M. Á., Curto, Y., Carceller, H., & Nacher, J. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00197 · Cited by 62
Zhang, R., Han, S., Liang, L., Chen, Y., Sun, B., Liang, N., Feng, Z., Zhou, H., Sun, C., Liu, H., et al. (2021) · Nano Energy · doi:10.1016/j.nanoen.2021.106192 · Cited by 61
Prefrontal cortex interneurons display dynamic sex-specific stress-induced transcriptomes
Girgenti, M. J., Wohleb, E. S., Mehta, S., Ghosal, S., Fogaca, M. V., & Duman, R. S. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0642-z · Cited by 53
Self-citationYang, X., Zhang, X., Shu, X., Gong, J., Yang, J., Li, B., Lin, J., Chai, Y., & Liu, J. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115390 · Cited by 56
Neurobiology of the rapid-acting antidepressant effects of ketamine: impact and opportunities
Shinohara, R., Aghajanian, G. K., & Abdallah, C. G. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.12.006 · Cited by 54
Fee, C., Prévot, T. D., Misquitta, K. A., Banasr, M., & Sibille, E. L. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.05.034 · Cited by 54
Self-citationLi, M., Sun, X., Wang, Z., & Li, Y. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02527-x · Cited by 50
“This is not only consistent with postmortem studies showing reductions in GAD67 mRNA levels in the hippocampus of MDD patients [23], but also with findings in animal models of depression [15, 16].”
BackgroundResultLiu, H., Ma, L.-L., Li, C., Cao, B., Jiang, Y., Han, L., Xu, R., Lin, J., & Zhang, D. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101281 · Cited by 48
Antidepressant mechanisms of ketamine: Focus on GABAergic inhibition
Lüscher, B., Feng, M., & Jefferson, S. J. (2020) · Advances in pharmacology · doi:10.1016/bs.apha.2020.03.002 · Cited by 44
Akimoto, H., Oshima, S., Sugiyama, T., Negishi, A., Nemoto, T., & Kobayashi, D. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.11.017 · Cited by 40
Hou, X., Rong, C., Wang, F., Liu, X., Sun, Y., & Zhang, H. (2020) · Neural Plasticity · doi:10.1155/2020/8858415 · Cited by 41
“Additionally, the protein and RNA levels of somatostatin and NPY are also decreased following stress exposure, suggesting these subsets of GABAergic neurons may be sensitive to chronic stress [70].”
BackgroundPlasticity of synapses and reward circuit function in the genesis and treatment of depression
Thompson, S. M. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-022-01422-1 · Cited by 40
“Somatostatin- and parvalbumin-expressing GABAergic interneurons are particularly affected in chronically stressed rats [209].”
BackgroundAlbrecht, A., Redavide, E., Regev-Tsur, S., Stork, O., & Richter‐Levin, G. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.11.002 · Cited by 41
The Role of Natural Products in Treatment of Depressive Disorder
Noori, T., Sureda, A., Sobarzo-Sánchez, E., & Shirooie, S. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220103140834 · Cited by 39
“Brain imaging and magnetic resonance spectroscopy confirm the reduction of GABAergic neurotransmission and GABA content in the prefrontal and occipital cortex of depressed patients [67].”
Sahafi, O. H., Sardari, M., Alijanpour, S., & Rezayof, A. (2023) · Brain Sciences · doi:10.3390/brainsci13050815 · Cited by 39
“The different isoforms of GAD, including GAD65 and GAD67, are commonly used as neurological markers to detect GABAergic neurons in terms of their activity [139].”
BackgroundSomatostatin and the pathophysiology of Alzheimer’s disease
Almeida, V. N. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102270 · Cited by 32
Turning the ′Tides on Neuropsychiatric Diseases: The Role of Peptides in the Prefrontal Cortex
Brockway, D. F., & Crowley, N. A. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.588400 · Cited by 33
Asim, M., Wang, H., & Waris, A. (2023) · Neuropeptides · doi:10.1016/j.npep.2023.102322 · Cited by 33
Benefits of animal models to understand the pathophysiology of depressive disorders
Czéh, B., & Simon, M. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110049 · Cited by 30
Bernardo, A. M., Lee, P., Marcotte, M. D., Mian, M. Y., Rezvanian, S., Sharmin, D., Kovačević, A., Savić, M. M., Cook, J. M., Sibille, E. L., et al. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01360-y · Cited by 30
Self-citationTroppoli, T. A., Zanos, P., Georgiou, P., Gould, T. D., Rudolph, U., & Thompson, S. M. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.11.024 · Cited by 29
Rezaei, S., Prévot, T. D., Vieira, É. L. M., & Sibille, E. L. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100761 · Cited by 34
“Brain-derived neurotrophic factor (BDNF) is a signaling neuropeptide mainly secreted from PNs and is important for dendritic compartments and GABAergic interneurons (adapted from Fee et al., 2017).”
BackgroundInfluentialSelf-citationXue, X., Pan, J., Zhang, H., Lu, Y., Mao, Q., & Ma, K. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115218 · Cited by 30
Miyata, S., Kumagaya, R., Kakizaki, T., Fujihara, K., Wakamatsu, K., & Yanagawa, Y. (2019) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2019.00131 · Cited by 32
“In animal studies, mice subjected to chronic mild stress, an animal model of depression, demonstrated a decrease in the mRNA level of SOM in the prefrontal cortex (Banasr et al., 2017).”
BackgroundZhang, F., Chen, H., Zhang, R.-X., Liu, Y., Kong, N., Guo, Y., & Xu, M. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165884 · Cited by 32
“A recent meta-analysis on 17 reports [54] and MRS studies have showed a reduction in glutamate and glutamine in the PFC of depressed patients and rat models [55,56].”
MethodAntidepressant Drugs for Seizures and Epilepsy: Where do we Stand?
Tallarico, M., Pisano, M., Leo, A., Russo, E., Citraro, R., & Sarro, G. D. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220627160048 · Cited by 34
“Preclinical studies of chronic stress also report reductions in levels of GABA synthetic enzymes and neuropeptides in the medial prefrontal cortex and other cortical brain regions [99, 108-110].”
BackgroundFogaça, M. V., Wu, M., Li, C., Li, X., Duman, R. S., & Picciotto, M. R. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01583-7 · Cited by 29
Self-citationDienel, S. J., Dowling, K. F., Barile, Z. J., Bazmi, H. H., Liu, A. Y., Vespoli, J. C., Fish, K. N., & Lewis, D. A. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.2972 · Cited by 28
Lourenço, J., Koukouli, F., & Bacci, A. (2020) · Cortex · doi:10.1016/j.cortex.2020.08.015 · Cited by 27
Lin, J., Ling, F., Huang, P., Chen, M., Song, M., Lu, K., & Wang, W. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.874137 · Cited by 24
“At present, at least 19 different GABAAR subunits (termed α1-6, β1-3, γ1-3, δ, ε, π, θ and ρ1-3) have been reported (51).”
Impact of stress on inhibitory neuronal circuits, our tribute to Bruce McEwen
Pérez-Rando, M., Carceller, H., Castillo-Gómez, E., Bueno-Fernández, C., García-Mompó, C., Gilabert‐Juan, J., Guirado, R., Pesarico, A. P., & Nácher, J. (2022) · Neurobiology of Stress · doi:10.1016/j.ynstr.2022.100460 · Cited by 25
Bueno-Fernández, C., Pérez-Rando, M., Alcaide, J., Coviello, S., Sandi, C., Castillo-Gómez, E., & Nácher, J. (2021) · Neurobiology of Stress · doi:10.1016/j.ynstr.2021.100322 · Cited by 24
The involvement of GABAergic system in the antidepressant-like effect of agmatine
Neis, V. B., Rosado, A. F., Olescowicz, G., Moretti, M., da Rosa, P. B., Platt, N., & Rodrigues, A. L. S. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01910-5 · Cited by 22
“In addition, the role of GABAergic system in the pathophysiology of MDD has been suggested by several studies that indicate (a) stressrelated changes in GABAergic function (Biggio et al. 1990; Banasr et al. 2017); (b) the ability of GABA agonists and antagonists to modulate the behavioral responses in models of depres…”
Disinhibition of somatostatin interneurons confers resilience to stress in male but not female mice
Jefferson, S. J., Feng, M., Chon, U., Guo, Y., Kim, Y., & Lüscher, B. (2020) · Neurobiology of Stress · doi:10.1016/j.ynstr.2020.100238 · Cited by 24
Hyperexcitability: From Normal Fear to Pathological Anxiety and Trauma
Rosen, J. B., & Schulkin, J. A. (2022) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2022.727054 · Cited by 25
Single Cell Transcriptome of Stress Vulnerability Network in mouse Prefrontal Cortex
Hing, B. W. Q., Mitchell, S. B., Filali, Y., Eberle, M., Hultman, I., Matkovich, M., Kasturirangan, M., Johnson, M., Wyche, W., Jimenez, A., et al. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.05.023 · Cited by 22
Moench, K. M., Breach, M. R., & Wellman, C. L. (2019) · Hormones and Behavior · doi:10.1016/j.yhbeh.2019.104615 · Cited by 22
“, 2019) in the number of parvalbumin-positive cells in mPFC of males have been found, while other have shown a decrease in the total amount of parvalbumin protein (Banasr et al., 2017).”
BackgroundYoon, S. H., Song, W. S., Chung, G., Kim, S. J., & Kim, M. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01294-z · Cited by 22
Newton, D. F., Oh, H., Shukla, R., Misquitta, K., Fee, C., Banasr, M., & Sibille, E. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.10.015 · Cited by 19
Self-citationMcCoy, A. M., Prévot, T. D., Mian, M. Y., Cook, J. M., Frazer, A., Sibille, E. L., Carreno, F. R., & Lodge, D. J. (2022) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyac035 · Cited by 18
“Similarly, stress vulnerability has been associated with decreased levels of GABA-related transcripts (Banasr et al., 2017; Sun et al., 2018), whereas increased expression of specific GABA receptors in the hippocampus appears to confer stress resiliency (Ardi et al.”
BackgroundSelf-citationTranscranial Magnetic Stimulation and Neocortical Neurons: The Micro-Macro Connection
Tian, D., & Izumi, S. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.866245 · Cited by 21
The Pathophysiological Underpinnings of Gamma-Band Alterations in Psychiatric Disorders
Palmisano, A., Pandit, S., Smeralda, C. L., Demchenko, I., Rossi, S., Battelli, L., Rivolta, D., Bhat, V., & Santarnecchi, E. (2024) · Life · doi:10.3390/life14050578 · Cited by 19
“Deep brain stimulation (DBS) of the ventral tegmental area (VTA) in a mouse model of depression was shown to induce an increase in the high γ -band phase coherence, which was correlated with an improvement in depressive-like behavior [311].”
BackgroundAnti-stress Properties of Atypical Antipsychotics
Sanson, A., & Riva, M. A. (2020) · Pharmaceuticals · doi:10.3390/ph13100322 · Cited by 19
“On the other end, chronic stress impairs GABAergic transmission by decreasing the levels of GAD67 in cortical brain regions [32], as well as by disrupting GABA uptake and release [33].”
BackgroundPromising new pharmacological targets for depression: The search for efficacy
Tsugiyama, L. E., de Moraes, R. C. M., Moraes, Y. A. C., & de Oliveira, J. F. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103804 · Cited by 16
Zhang, S., Cheon, M., Park, H.-Y., Kim, T., & Chung, C. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.12.020 · Cited by 16
Molecular Biological Aspects of Depressive Disorders: A Modern View
Ushakova, V. M., Morozova, A. Y., Reznik, A. M., Kostyuk, G. P., & Chekhonin, V. P. (2020) · Molecular Biology · doi:10.1134/s0026893320050118 · Cited by 17
Tripathi, K. K., Demiray, Y. E., Kliche, S., Jing, L., Hazra, S., Hazra, J. D., Richter‐Levin, G., & Stork, O. (2021) · Neurobiology of Stress · doi:10.1016/j.ynstr.2021.100350 · Cited by 16
“…gyrus (DG) and CA3, amygdala, bed nucleus of the stria terminalis (BNST), and various hypothalamic subregions, following conditioned fear (Bergado-Acosta et al., 2008; Heldt and Ressler, 2007), acute stress and chronic stress (Banasr et al., 2017; Bowers et al., 1998; Makinson et al., 2015).”
BackgroundInfluentialPérez-Valenzuela, E., Hudson, R., Uzuneser, T. C., Felice, M. D., Szkudlarek, H. J., Rushlow, W. J., & Laviolette, S. R. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230912101441 · Cited by 15
When the Stars Misfire: Astrocytic Dysfunctions in Major Depressive Disorder
González-Arias, C., & Perea, G. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04483-y · Cited by 16
“…or with congenital help-less behaviour (cH), a genetic rat model for human depression, displayed significantly lower expression of the GABA transporter GAT3 in PFC, compared to control littermates, which may be associated with reduced GABA levels in mice with depression-like behaviours [ 86–88].”
Calretinin+-neurons-mediated GABAergic inhibition in mouse prefrontal cortex
Saffari, R., Grotefeld, K., Kravchenko, M., Zhang, M., & Zhang, W. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109658 · Cited by 15
Yang, X.-Y., Ma, Z.-L., Storm, D. R., Cao, H., & Zhang, Y.-Q. (2021) · World Journal of Psychiatry · doi:10.5498/wjp.v11.i2.35 · Cited by 12
Hu, L., Qiu, M., Fan, W., Wang, W.-E., Liu, S., Liu, X.-Q., Liu, S.-W., Shen, Z.-J., Zheng, Y., Liu, G., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1433026 · Cited by 13
Interleukin 6 Dependent Synaptic Plasticity in a Social Defeat-Susceptible Prefrontal Cortex Circuit
Esquivel‐Rendon, E., Vargas‐Mireles, J., Cuevas‐Olguin, R., Miranda‐Morales, M., Acosta-Mares, P., García‐Oscos, F., Pineda, J. C., Salgado, H., Rose‐John, S., & Atzori, M. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.07.002 · Cited by 12
Bansal, Y., Fee, C., Misquitta, K. A., Codeluppi-Arrowsmith, S. A., Sibille, E. L., Berman, R., Coric, V., Sanacora, G., & Banasr, M. (2023) · Complex Psychiatry · doi:10.1159/000529534 · Cited by 14
Self-citationDowling, K. F., Dienel, S. J., Barile, Z. J., Bazmi, H. H., & Lewis, D. A. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.04.003 · Cited by 12
Rodrigues, D., Santa, C., Manadas, B. J., & Monteiro, P. (2024) · eNeuro · doi:10.1523/eneuro.0053-24.2024 · Cited by 13
“Additionally, alterations in the levels of various genes and proteins involved in GABAergic signaling have also been documented (Gilabert-Juan et al., 2013; Ma et al., 2016; Shepard et al., 2016; Banasr et al., 2017).”
BackgroundDynamic Behavioral and Molecular Changes Induced by Chronic Restraint Stress Exposure in Mice
Prévot, T. D., Chatterjee, D., Knoch, J., Codeluppi-Arrowsmith, S. A., Misquitta, K. A., Fee, C., Newton, D. F., Oh, H., Sibille, E. L., & Banasr, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010167 · Cited by 13
“Reductions in VIP levels have also been reported following chronic stress [12].”
InfluentialSelf-citationМолекулярно-биологические аспекты депрессивных состояний: современный взгляд на проблему
Ushakova, V. M., Морозова, А. Ю., Reznik, A. M., Kostyuk, G. P., & Chekhonin, V. P. (2020) · Molecular Biology · doi:10.31857/s0026898420050110 · Cited by 12
Molecular characterization of the stress network in individuals at risk for schizophrenia
Meijer, M., Keo, A., van Leeuwen, J. M. C., Dzyubachyk, O., Meijer, O. C., Vinkers, C. H., & Mahfouz, A. E. (2021) · Neurobiology of Stress · doi:10.1016/j.ynstr.2021.100307 · Cited by 10
Frackowiak, J., Mazur‐Kolecka, B., Mehta, P. D., & Węgiel, J. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00923-8 · Cited by 10
Perić, I., Lješević, M., Beskoski, V. P., Nikolic, M. R., & Filipović, D. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06180-y · Cited by 11
Anxiety-like behavior and GABAergic system in ovariectomized rats exposed to chronic mild stress
Tongta, S., Daendee, S., & Kalandakanond‐Thongsong, S. (2022) · Physiology & Behavior · doi:10.1016/j.physbeh.2022.114014 · Cited by 10
Chronic activation of a negative engram induces behavioral and cellular abnormalities
Jellinger, A. L., Suthard, R. L., Yuan, B., Surets, M., Ruesch, E. A., Caban, A. J., Liu, X. S., Shpokayte, M., & Ramirez, S. (2024) · eLife · doi:10.7554/elife.96281 · Cited by 8
“Recent work has suggested a framework where stress may compromise GABAergic signaling in the hippocampus (Alaiyed et al., 2020; Banasr et al., 2017; Albrecht et al., 2021), allowing a state of hippocampal hyperactivity to persist.”
BackgroundFrackowiak, J., & Mazur‐Kolecka, B. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1160967 · Cited by 8
Somatostatin signaling modulates binge drinking behavior via the central nucleus of the amygdala
Robinson, S. L., & Thiele, T. E. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109622 · Cited by 8
Bangsumruaj, J., Kijtawornrat, A., & Kalandakanond‐Thongsong, S. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.113985 · Cited by 8
Lin, H., Lin, W., Lin, F., Liu, C.-Y., Che, C., & Huang, H. (2022) · Computational Intelligence and Neuroscience · doi:10.1155/2022/6799285 · Cited by 8
RetractedLi, N., Gao, Y., Zhang, Y., & Deng, Y. (2023) · Journal of Proteomics · doi:10.1016/j.jprot.2023.104887 · Cited by 8
Altered GABAergic inhibition in CA1 pyramidal neurons modifies despair-like behavior in micePreprint
Yoon, S. H., Chung, G., Song, W. S., Oh, S. P., Kim, J.-J., Kim, S. J., & Kim, M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.18.953786 · Cited by 7
Memory impairments in rodent depression models: A link with depression theories.
Sałaciak, K., Koszałka, A., Lustyk, K., Żmudzka, E., Jagielska, A., & Pytka, K. (2023) · Progress in Neuro-psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110774 · Cited by 6
Ortiz, J. B., Newbern, J. M., & Conrad, C. D. (2020) · Hippocampus · doi:10.1002/hipo.23285 · Cited by 7
“campus and prefrontal cortex, in chronically stressed rodents (Banasr et al., 2017; Czeh et al., 2015).”
BackgroundZhu, Y., Qu, Y., Zhang, J., Hou, J., Fang, J., Shen, J., Xu, C. S., Huang, M., Qiao, H., & An, S.-C. (2021) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000660 · Cited by 6
“Chronic stress exposure decreases the innervation and function of GABAergic axons and the levels of GAD67 and vesicular GABA transporter in the PFC (GilabertJuan et al., 2013; Ma et al., 2016; Banasr et al., 2017).”
BackgroundKovačević, S., Pavković, Ž., Brkljačić, J. M., Elaković, I., Milutinović, D. V., Djordjevic, A. D., & Pešić, V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111721 · Cited by 6
Unveiling the enigma of anxiety disorders and depression: from pathogenesis to treatment
Pan, H., Xia, T., Zhang, Y., Zhang, H., Xu, M., Guo, J., Liu, Y., Bai, X.-Y., Liu, Q., Liu, W.-Z., et al. (2025) · Science China Life Sciences · doi:10.1007/s11427-025-3024-y · Cited by 8
“…alter GABA concentrations and modulate expression of GABAergic system components, such as glutamate decarboxylase (GAD), GABA transporter-3 (Banasr et al., 2017; Ma et al., 2016), and interneuron (IN) markers, including somatostatin (SST) and neuropeptide Y (NPY) (Banasr et al., 2017).”
Troppoli, T. A., & Thompson, S. M. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.10.036 · Cited by 7
Shintani, Y., Hayata‐Takano, A., Takasaki, I., Kurihara, T., Miyata, A., Yamano, Y., Ikuta, M., Takeshita, R., Murata, K., Oguri, T., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03209-4 · Cited by 4
Chahuan, S., Grover, S., & Singh, S. (2022) · Drug and Chemical Toxicology · doi:10.1080/01480545.2022.2105862 · Cited by 4
“The chronic unpredictable stress (CUS) model is useful to develop a depression-like state in animals that resembles clinical symptoms of depression and other clinical neurological changes (Banasr et al. 2017).”
BackgroundNeuroprotective roles of neurotrophic growth factors in mood disorders
Jiang, C. S., & Salton, S. R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814037-6.00010-0 · Cited by 4
Metadata
- Authors
- Banasr, M., Lepack, A., Fee, C., Duric, V., Maldonado-Aviles, J., DiLeone, R., Sibille, E., Duman, R. S., & Sanacora, G.
- Affiliations
- University of Toronto (CA)
- Yale University (US)
- Campbell Family Mental Health Research Institute (CA)
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
- Corresponding author
- Banasr, Mounira
- ORCID
- Venue
- Chronic Stress
- Publisher
- SAGE Publications
- Published
- 2017-02
- Volume
- 1
- ISSN
- 2470-5470 (ISSN-L)
- PMC
- PMC5565173
- OpenAlex
- W2745251411
- Cited by
- 135
- References
- 100
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 20 · 2023: 19 · 2022: 17 · 2021: 17 · 2020: 21 · 2019: 21 · 2018: 7 · 2017: 1
- FWCI
- 6.69
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Chronic Stress (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (1r01mh095104-01)
- National Institute of Mental Health (R01MH081211, R01MH071676, R01-MH095104, R01MH105910)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- GABAergic interneurons, chronic unpredictable mild stress, major depressive disorder, GAD67, GAD65, somatostatin, neuropeptide Y, prefrontal cortex, hippocampus, corticosterone, dexamethasone, calcium-binding proteins, neuropeptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.